(Q85045912)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850021%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

[COPD: bronchial and systemic inflammation] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850021%20AND%20SRC:MED&resulttype=core&format=json

chronic obstructive pulmonary disease

14 February 2020

main subject

1 reference

inferred from title

systemic inflammation

1 reference

inferred from title

author name string

Ciro Casanova Macario

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850021%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Juan Pablo de Torres Tajes

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850021%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Elizabeth Córdoba Lanus

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850021%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

1 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850021%20AND%20SRC:MED&resulttype=core&format=json

Archivos de Bronconeumologia

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850021%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

46 Suppl 4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850021%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

9-15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850021%20AND%20SRC:MED&resulttype=core&format=json

[Diagnosis and management of chronic obstructive pulmonary disease: joint guidelines of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Latin American Thoracic Society (ALAT)]

14 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Pathophysiology of airflow limitation in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

The nature of small-airway obstruction in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Pulmonary biomarkers in chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Differences in Airway Inflammation in Patients with Fixed Airflow Obstruction Due to Asthma or Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Immunologic aspects of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Systemic and local inflammation in asthma and chronic obstructive pulmonary disease: is there a connection?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

A novel, orally active CXCR1/2 receptor antagonist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

CXCR3 and CCR5 Chemokines in Induced Sputum From Patients With COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Lymphoid follicle cells in chronic obstructive pulmonary disease overexpress the chemokine receptor CXCR3.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Relation between duration of smoking cessation and bronchial inflammation in COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Variability and effects of bronchial colonisation in patients with moderate COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Severity of airflow limitation is associated with severity of airway inflammation in smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Lung dendritic cell expression of maturation molecules increases with worsening chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Local and Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Relationships among bacteria, upper airway, lower airway, and systemic inflammation in COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Airway and systemic inflammation and decline in lung function in patients with COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Systemic Effects of Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

[COPD and systemic inflammation. A link for comorbidity]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Increased systemic inflammation is a risk factor for COPD exacerbations

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

The cytokine network in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Profiling serum biomarkers in patients with COPD: associations with clinical parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Chronic airflow obstruction and markers of systemic inflammation: results from the BOLD study in Iceland

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

C-reactive protein levels and clinically important predictive outcomes in stable COPD patients

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Body Mass, Fat-Free Body Mass, and Prognosis in Patients with Chronic Obstructive Pulmonary Disease from a Random Population Sample: Findings from the Copenhagen City Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Possible mechanisms underlying the development of cachexia in COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

[COPD disease and malnutrition]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Cytokine profile in quadriceps muscles of patients with severe COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Circulating matrix metalloproteinase-9 and osteoporosis in patients with chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Health, treatment and health care resources consumption profile among Spanish adults with diabetes and chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Anxiety and depression in COPD patients: The roles of gender and disease severity.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Anemia and inflammation in COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

C-reactive protein levels and survival in patients with moderate to very severe COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Chronic obstructive pulmonary disease and inhaled steroids alter surfactant protein D (SP-D) levels: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Polymers and inflammation: disease mechanisms of the serpinopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Tumour necrosis factor gene polymorphisms are associated with COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years' research

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

TNF-alpha-, TNF-beta-, IL-6-, and IL-10-promoter polymorphisms in patients with chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Raised CRP levels mark metabolic and functional impairment in advanced COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Associations of IL6 polymorphisms with lung function decline and COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Association of IL-6 gene polymorphisms and COPD in a Spanish population.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

C-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Polymorphisms in the interleukin-8 gene in patients with chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Association of IL8, CXCR2 and TNF-alpha polymorphisms and airway disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Histone acetylation and deacetylation: importance in inflammatory lung diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

Decreased histone deacetylase activity in chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2810%2970027-2

7 January 2021

10.1016/S0300-2896(10)70027-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850021%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference